The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival outcomes for African-American (AA) vs matched Caucasian (CAU) patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with sipuleucel-T (sip-T).
 
David I. Quinn
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Exelixis; Genentech/Roche; Merck Serono; Merck Sharp & Dohme; Novartis; Peloton Therapeutics; Pfizer; Piramal Life Science; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Exelixis; Genentech/Roche; Merck Serono; Merck Sharp & Dohme; Novartis; Peloton Therapeutics; Pfizer; Piramal Life Science; Sanofi
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Millennium (Inst); Sanofi (Inst)
 
Stephen J. Freedland
Stock and Other Ownership Interests - Armune Bioscience; Parallel6
Consulting or Advisory Role - Armune Bioscience; Astellas Pharma; Bayer; Dendreon; GenomeDx; Janssen Biotech; MDxHealth; Medivation; Parallel6; Sanofi
Speakers' Bureau - Dendreon
Research Funding - Amgen (Inst); Bayer (Inst); Dendreon (Inst); GenomeDx (Inst); Janssen Biotech (Inst); Metabolon (Inst); Mitomics (Inst); Myriad Genetics (Inst); POM Wonderful (Inst); Progenika (Inst)
Travel, Accommodations, Expenses - GenomeDx; Myriad Genetics; Sanofi
 
Elisabeth I. Heath
Honoraria - Bayer; Dendreon; Sanofi
Consulting or Advisory Role - Agensys
Research Funding - Agensys (Inst); Celgene (Inst); Celldex (Inst); Dendreon (Inst); Genentech/Roche (Inst); Inovio Pharmaceuticals (Inst); Millennium (Inst); Seagen (Inst); Tokai Pharmaceuticals (Inst)
 
Ronald F. Tutrone
Stock and Other Ownership Interests - Novartis; Nymox; Sophiris Bio
Consulting or Advisory Role - 3D Biopsy; Medivation/Astellas; Pfizer
Speakers' Bureau - Dendreon; Medivation/Astellas
Research Funding - Advaxis (Inst); Allena Pharmaceuticals (Inst); Allergan (Inst); American Medical Systems (Inst); Bayer (Inst); Boston Scientific (Inst); Genentech/Roche (Inst); Genomic Health (Inst); Janssen Oncology (Inst); MDxHealth (Inst); Medivation/Astellas (Inst); Mundipharma (Inst); Neotract (Inst); Nymox (Inst); Sophiris Bio (Inst)
 
David G. McLeod
No Relationships to Disclose
 
Nadeem Anwar Sheikh
Employment - Dendreon
Stock and Other Ownership Interests - Valeant Pharmaceuticals International
 
Nancy N. Chang
Employment - Dendreon
Stock and Other Ownership Interests - Dendreon
 
A. Oliver Sartor
Consulting or Advisory Role - Bayer; Bellicum Pharmaceuticals; Bristol-Myers Squibb; Celgene; Johnson & Johnson; Medivation; Oncogenex; Sanofi; Tokai Pharmaceuticals
Research Funding - Bayer (Inst); Dendreon (Inst); Endocyte (Inst); Innocrin Pharma (Inst); Johnson & Johnson (Inst); Sanofi (Inst)